Stars are more colorful than you think! Patience will reveal them; head outside tonight to see summer’s multi-hued stars.

In a report released yesterday, Myles Minter from William Blair maintained a Buy rating on Argenx Se. The company’s shares closed today at $591.99. Take advantage of TipRanks Premium at 50% off!

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Mars gets lost as it sinks deep into the sun’s afterglow. Meanwhile, Jupiter climbs above the predawn eastern horizon to join brilliant Venus.

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis continues the discussion on mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines and ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Arcturus Therapeutics (ARCT – Research Report) and Pharvaris (PHVS – Research ...

COLORADO SPRINGS, Colo. (KKTV) - The Colorado Springs Police Department (CSPD) is asking for help finding a missing 76-year-old man.

There’s a chance we could see a white dwarf star explosion this year. T Coronae Borealis, a binary star system and recurrent nova located roughly 3,000 light-years from Earth, is expected to erupt ...

Get the detailed quarterly/annual income statement for Arcturus Therapeutics Holdings Inc. (ARCT). Find out the revenue, expenses and profit or loss over the last fiscal year.

5 analysts have expressed a variety of opinions on Arcturus Therapeutics (NASDAQ:ARCT) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below summarizes ...

Review the current valuation for Arcturus Therapeutics Holdings Inc (ARCT:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.